Clinical Trials Browser

OTHER × Interventional × Infectious Mononucleosis × Clear all

NCT04138875 2022-06-23

A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB)

Phase 2 Withdrawn

Other hematologic neoplasm

Infectious Mononucleosis, Hematologic Neoplasms

NCT00274404 2011-10-27

Controlled Trial of Valacyclovir in Infectious Mononucleosis

Phase 1/2 Completed

Infectious Mononucleosis, Epstein-Barr Virus Infections